These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8032896)
1. Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease. Holemans S; Javoy-Agid F; Agid Y; De Paermentier F; Laterre EC; Maloteaux JM Brain Res; 1994 Apr; 642(1-2):327-33. PubMed ID: 8032896 [TBL] [Abstract][Full Text] [Related]
2. Major differences in CNS sulfonylurea receptor distribution between the rat (newborn, adult) and turtle. Xia Y; Haddad GG J Comp Neurol; 1991 Dec; 314(2):278-89. PubMed ID: 1787178 [TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro regulation of [3H]glyburide binding to brain sulfonylurea receptors in obesity-prone and resistant rats by glucose. Levin BE; Dunn-Meynell AA Brain Res; 1997 Nov; 776(1-2):146-53. PubMed ID: 9439807 [TBL] [Abstract][Full Text] [Related]
4. Photoaffinity labeling of the cerebral sulfonylurea receptor using a novel radioiodinated azidoglibenclamide analogue. Schwanstecher M; Löser S; Chudziak F; Bachmann C; Panten U J Neurochem; 1994 Aug; 63(2):698-708. PubMed ID: 8035194 [TBL] [Abstract][Full Text] [Related]
5. Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol. Chinaglia G; Alvarez FJ; Probst A; Palacios JM Neuroscience; 1992 Jul; 49(2):317-27. PubMed ID: 1436470 [TBL] [Abstract][Full Text] [Related]
6. The binding properties of the particulate and solubilized sulfonylurea receptor from cerebral cortex are modulated by the Mg2+ complex of ATP. Schwanstecher M; Schaupp U; Löser S; Panten U J Neurochem; 1992 Oct; 59(4):1325-35. PubMed ID: 1402884 [TBL] [Abstract][Full Text] [Related]
7. The mitochondrial sulfonylurea receptor: identification and characterization. Szewczyk A; Wójcik G; Lobanov NA; Nałecz MJ Biochem Biophys Res Commun; 1997 Jan; 230(3):611-5. PubMed ID: 9015372 [TBL] [Abstract][Full Text] [Related]
8. Interaction of fluorescein derivatives with glibenclamide binding sites in rat brain. Holemans S; Feron O; Octave JN; Maloteaux JM Neurosci Lett; 1995 Jan; 183(3):183-6. PubMed ID: 7739789 [TBL] [Abstract][Full Text] [Related]
9. The high-affinity sulphonylurea receptor regulates KATP channels in nerve terminals of the rat motor cortex. Lee K; Dixon AK; Rowe IC; Ashford ML; Richardson PJ J Neurochem; 1996 Jun; 66(6):2562-71. PubMed ID: 8632183 [TBL] [Abstract][Full Text] [Related]
10. ATP/ADP binding sites are present in the sulfonylurea binding protein associated with brain ATP-sensitive K+ channels. Bernardi H; Fosset M; Lazdunski M Biochemistry; 1992 Jul; 31(27):6328-32. PubMed ID: 1627571 [TBL] [Abstract][Full Text] [Related]
11. Metabolic inhibition impairs ATP-sensitive K+ channel block by sulfonylurea in pancreatic beta-cells. Mukai E; Ishida H; Kato S; Tsuura Y; Fujimoto S; Ishida-Takahashi A; Horie M; Tsuda K; Seino Y Am J Physiol; 1998 Jan; 274(1):E38-44. PubMed ID: 9458745 [TBL] [Abstract][Full Text] [Related]
12. Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex. Schwanstecher M; Brandt C; Behrends S; Schaupp U; Panten U Br J Pharmacol; 1992 Jun; 106(2):295-301. PubMed ID: 1393263 [TBL] [Abstract][Full Text] [Related]
13. Do adipocytes contain high affinity sulfonylurea receptors. Rajan AS; Luo ZT; Kahn BB; Comstock JP; Cushman SW; Boyd AE Endocrinology; 1994 Mar; 134(3):1581-8. PubMed ID: 8119201 [TBL] [Abstract][Full Text] [Related]
14. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride. Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD Biochim Biophys Acta; 1994 May; 1191(2):278-90. PubMed ID: 8172913 [TBL] [Abstract][Full Text] [Related]
15. Putative subunits of the rat mesangial KATP: a type 2B sulfonylurea receptor and an inwardly rectifying K+ channel. Szamosfalvi B; Cortes P; Alviani R; Asano K; Riser BL; Zasuwa G; Yee J Kidney Int; 2002 May; 61(5):1739-49. PubMed ID: 11967023 [TBL] [Abstract][Full Text] [Related]
16. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242 [TBL] [Abstract][Full Text] [Related]
17. Regional distribution of sulfonylurea receptors in the brain of rodent and primate. Zini S; Tremblay E; Pollard H; Moreau J; Ben-Ari Y Neuroscience; 1993 Aug; 55(4):1085-91. PubMed ID: 8232899 [TBL] [Abstract][Full Text] [Related]
18. Sulfonylurea binding sites associated with ATP-regulated K+ channels in the central nervous system: autoradiographic analysis of their distribution and ontogenesis, and of their localization in mutant mice cerebellum. Mourre C; Widmann C; Lazdunski M Brain Res; 1990 Jun; 519(1-2):29-43. PubMed ID: 2118822 [TBL] [Abstract][Full Text] [Related]
19. Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide. Ueda K; Komine J; Matsuo M; Seino S; Amachi T Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1268-72. PubMed ID: 9990013 [TBL] [Abstract][Full Text] [Related]
20. The binding properties of the solubilized sulfonylurea receptor from a pancreatic B-cell line are modulated by the Mg(++)-complex of ATP. Schwanstecher M; Behrends S; Brandt C; Panten U J Pharmacol Exp Ther; 1992 Aug; 262(2):495-502. PubMed ID: 1501109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]